 | Up a level |
Simon, A; Müllenborn, E; Prelog, M; Schenk, W; Holzapfel, J; Ebinger, F; Klabunde-Cherwon, A; Faber, J; Groll, A H; Masjosthusmann, K; Dohna-Schwake, C; Beutel, K; Dirkwinkel, E; Lehrnbecher, T; Ammann, R A; Müller, A (2012). Use of linezolid in neonatal and pediatric inpatient facilities-results of a retrospective multicenter survey. European journal of clinical microbiology & infectious diseases, 31(7), pp. 1435-42. Berlin: Springer 10.1007/s10096-011-1461-1
Krudewig, J; Baumann, U; Bernuth von, H; Borte, M; Burkhard-Meier, U; Dueckers, G; Foerster-Waldl, E; Franke, K; Habermehl, P; Hönig, M; Kern, W; Kösters, K; Kugel, K; Lehrnbecher, T; Liese, J; Marks, R; Müller, G A; Müller, R; Nadal, D; Peter, H-H; ... (2012). [Interdisciplinary AWMF guideline for the treatment of primary antibody deficiencies]. Klinische Pädiatrie, 224(6), pp. 404-15. Stuttgart: Thieme 10.1055/s-0032-1323837
Lehrnbecher, T; Attarbaschi, A; Duerken, M; Garbino, J; Gruhn, B; Kontny, U; Lüer, S; Phillips, R; Scholz, J; Wagner, H J; Wiesel, T; Groll, A H (2010). Posaconazole salvage treatment in paediatric patients: a multicentre survey. European journal of clinical microbiology & infectious diseases, 29(8), pp. 1043-1045. Berlin: Springer 10.1093/jac/dk1009
